A simple algorithm for a clinical step-by-step approach in the management of hypertrophic cardiomyopathy

Georgios Efthimiadis1, Thomas Zegkos2, Despoina Parcharidou2

  • 11st Cardiology department, Laboratory of Cardiomyopathies and Inherited Cardiac Diseases, AHEPA University hospital, Thessaloniki 54636, Greece.

Future Cardiology
|February 22, 2021
PubMed

Insights

Hypertrophic cardiomyopathy (HCM), a common inherited heart disease, requires a structured diagnostic and management approach. This review outlines a simple algorithm for newly diagnosed HCM patients, focusing on risk stratification and tailored therapeutic strategies.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiac condition, affecting approximately 0.2% of the population.
  • It follows an autosomal dominant inheritance pattern, necessitating thorough family history evaluation.
  • Differentiating HCM from other causes of left ventricular hypertrophy, like cardiac amyloidosis, is crucial for accurate diagnosis.

Purpose of the Study:

  • To present a simplified management algorithm for patients newly diagnosed with HCM.
  • To emphasize the importance of early etiological diagnosis and risk stratification.
  • To describe therapeutic strategies based on disease presentation and progression.

Main Methods:

  • Initial assessment includes clinical examination, detailed medical and family history, and electrocardiography (ECG).
  • Cardiovascular imaging and ambulatory electrocardiography are key diagnostic tools.
  • Etiological diagnosis to distinguish genetic HCM from phenocopies is essential.
  • Cardiopulmonary exercise testing may be utilized for further assessment.

Main Results:

  • The diagnostic process aids in differentiating HCM from other conditions causing left ventricular hypertrophy.
  • Risk stratification for sudden cardiac death is a critical component of patient management.
  • The algorithm facilitates tailored therapeutic strategies for obstructive, non-obstructive, and end-stage HCM.

Conclusions:

  • A systematic approach is vital for managing patients with hypertrophic cardiomyopathy.
  • Accurate diagnosis and risk stratification guide effective treatment decisions.
  • This algorithm provides a framework for comprehensive HCM patient care.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
145
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
121
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
146
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
147
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
125
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
113